Advancing Innovation Through Collaboration
Developing a new diagnostic platform requires coordinated expertise across clinical research, medical-device engineering, ultrasound science, regulatory strategy, manufacturing, and commercialization.
OtoNexus works with selected clinical, research, engineering, and pediatric-device organizations to advance its investigational through-air ultrasound platform. These relationships help the company access specialized expertise, development resources, and clinical perspectives as the technology progresses toward future regulatory review.
Investigational device. Not cleared by the FDA. Not available for commercial sale.
A Differentiated Technology Platform
Bringing Ultrasound to the Ear Exam
OtoNexus is developing proprietary technology that applies through-air ultrasound to middle-ear assessment in a compact otoscope platform.
The system is being designed to collect ultrasound information during the ear examination and use AI-assisted signal analysis to provide objective information to support clinical decision-making.
This combination of ultrasound sensing, AI-assisted analysis, and an otoscope-based workflow represents a differentiated approach to addressing diagnostic uncertainty in middle-ear conditions.
Opportunities for Strategic Collaboration
Clinical and Pediatric Device Collaboration
OtoNexus engages with clinical investigators and pediatric-device organizations to inform clinical research, evidence generation, and the development of technology intended for use in pediatric care.
Technology and Engineering Collaboration
The company works with specialized research and engineering organizations in areas including ultrasound components, signal acquisition, device integration, and manufacturability.
Strategic Collaboration
OtoNexus welcomes discussions with organizations whose clinical, technical, manufacturing, or commercial capabilities may complement the company’s development program and broader platform strategy.
Addressing an Important Clinical Challenge
Middle-ear conditions are common, particularly in children, yet evaluation can depend on clinical findings that may be difficult to assess consistently during a routine ear examination.
OtoNexus is developing its technology to add objective information to this process, with three broader healthcare goals:
More Timely Decisions
Provide objective information during the patient visit to support more timely clinical decision-making.
Antibiotic Stewardship
Support informed treatment decisions and the judicious use of antibiotics.
Healthcare Efficiency
Help address costs associated with diagnostic uncertainty and unnecessary care.
Built Around a Simple Clinical Concept
Position. Scan. Analyze. Inform.
Why Partner with OtoNexus?
Proprietary Technology
A differentiated through-air ultrasound approach being developed to provide objective information about middle-ear conditions.
Intellectual Property
A growing intellectual-property portfolio supporting the OtoNexus technology platform.
Multidisciplinary Expertise
Experience spanning ultrasound, artificial intelligence, medical-device development, clinical research, regulatory strategy, product development, and commercialization.
Platform Potential
A technology platform with potential applications extending beyond the company's initial focus on middle-ear assessment.
Advancing Through Development
OtoNexus continues to advance the ultrasound otoscope through engineering, clinical, regulatory, and commercialization-readiness activities, including participation in the FDA Safer Technologies Program.
Investigational device. Not cleared by the FDA. Not available for commercial sale.
Let's Explore What's Possible
Interested in exploring a strategic relationship with OtoNexus?
We welcome conversations with organizations whose capabilities and strategic interests may align with the development and future potential of the OtoNexus technology platform.